Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Sanders Bill Proposes Prize Fund to Help Lower Costs of HIV/AIDS Drugs

May 18, 2012

Sanders Bill Proposes Prize Fund to Help Lower Costs of HIV/AIDS Drugs

Sen. Bernie Sanders (I-VT) introduced a bill that he claims could help reduce the cost of HIV drugs in the United States by thousands of dollars, making them as cheap as subsidized drugs in Africa. Sanders' legislation, S. 1138, proposes to replace the drugmakers' exclusive marketing rights for new HIV and AIDS drugs with rewards of money from the government.

According to Sen. Sanders' website, the government patent system granting monopolies to pharmaceutical companies that develop new drugs is responsible for the high cost of drugs in the United States. The Sanders bill instead would create a $3 billion annual prize fund to reward the discovery of new treatments for HIV/AIDS.

In many developing countries, US drugmakers wave their patent rights as part of the President's Emergency Plan for AIDS Relief, making the annual cost of HIV drugs manageable for low-income people living with HIV. Conversely, the annual cost of HIV drugs in the United States can be between $30,000 and $40,000.

Advertisement

Drugmakers argue that they will be unable to bring HIV drugs to the market without the patent rights to make production profitable. They also contend that programs such as the AIDS Drug Assistance Programs (ADAP), which provide HIV drugs for people who cannot afford the cost, are available for low-income people living with HIV.

The reality, however, is that the confluence of the economic recession and the ever-growing number of people living with HIV has made ADAP and pharmaceutical assistance programs that provide HIV drugs for low-income individuals struggle to cover all the people that need HIV drugs. As of May 10, 2,759 people in 10 states are on ADAP waiting lists, and 16 states have cost-containment measures in place that limit access to ADAP.

AIDS United met with Senator Sanders' office to give input on the bill and is supportive of the spirit of the bill to lower costs of HIV medication for people in the United States living with HIV.

Click here to read Senator Sanders' opening statement to the Senate subcommittee on Primary Health and Aging, of which he is the Chairman.



  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by AIDS United. Visit AIDS United's website to find out more about their activities and publications.
 
See Also
National HIV/AIDS Strategy for the United States: Executive Summary
U.S. Announces First National HIV/AIDS Strategy
More on U.S. HIV/AIDS Policy

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement